APA (7th ed.) Citation

SM, B., SE, P., SJ, K., LM, v. d. G., HC, G., M, M., & M, d. J. (2014). Peptide receptor radionuclide therapy (PRRT) with [(177)Lu-DOTA(0),Tyr(3)]octreotate in combination with RAD001 treatment: Further investigations on tumor metastasis and response in the rat pancreatic CA20948 tumor model. EJNMMI research, 4, 21. https://doi.org/10.1186/s13550-014-0021-y

Chicago Style (17th ed.) Citation

SM, Bison, Pool SE, Koelewijn SJ, van der Graaf LM, Groen HC, Melis M, and de Jong M. "Peptide Receptor Radionuclide Therapy (PRRT) with [(177)Lu-DOTA(0),Tyr(3)]octreotate in Combination with RAD001 Treatment: Further Investigations on Tumor Metastasis and Response in the Rat Pancreatic CA20948 Tumor Model." EJNMMI Research 4 (2014): 21. https://doi.org/10.1186/s13550-014-0021-y.

MLA (9th ed.) Citation

SM, Bison, et al. "Peptide Receptor Radionuclide Therapy (PRRT) with [(177)Lu-DOTA(0),Tyr(3)]octreotate in Combination with RAD001 Treatment: Further Investigations on Tumor Metastasis and Response in the Rat Pancreatic CA20948 Tumor Model." EJNMMI Research, vol. 4, 2014, p. 21, https://doi.org/10.1186/s13550-014-0021-y.